Patent details

EP3368060 Title: GLUCAGON RECEPTOR AGONISTS

Basic Information

Publication number:
EP3368060
PCT Application Number:
US2016056959
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167856673
PCT Publication Number:
WO2017074714
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GLUCAGON RECEPTOR AGONISTS
French Title of Invention:
AGONISTES DU RÉCEPTEUR DU GLUCAGON
German Title of Invention:
GLUCAGONREZEPTORAGONISTEN
SPC Number:

Dates

Filing date:
14/10/2016
Grant date:
24/06/2020
EP Publication Date:
05/09/2018
PCT Publication Date:
04/05/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/06/2020
EP B1 Publication Date:
24/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/10/2023
Expiration date:
14/10/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/06/2020
 
 

Name:
Eli Lilly and Company
Address:
Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
08/07/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
ALSINA-FERNANDEZ, Jorge
Address:
United States (US)

2

Name:
COSKUN, Tamer
Address:
United States (US)

Priority

Priority Number:
201562246199 P
Priority Date:
26/10/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/26; C07K 14/605;

Publication

European Patent Bulletin

Issue number:
202026
Publication date:
24/06/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
20/09/2022
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
09/07/2020 Outgoing Correspondence 1
08/07/2020 Power Of Attorney 1